Therapeutics: TOR signaling pathway regulator (TIPRL); protein phosphatase 2 regulatory subunit A α (PPP2R1A)

Cancer

INDICATION: Endometrial cancer

Cell culture studies suggest inhibiting TIPRL could

Read the full 94 word article

User Sign In